 |
Vikhyat Bebarta
Professor
M.D., 1998, George Washington University School of Medicine and Health Sciences
|
 |
Kian Behbakht
Associate Professor
M.D., 1989, Ohio State University College of Medicine
Innovative new treatments for ovarian cancers. |
 |
Timothy A. Benke
Associate Professor
M.D./Ph.D., 1995, Baylor College of Medicine
Mechanisms of synaptic plasticity and impacts of development and epilepsy. |
 |
Hematopoietic Stem Cell Development and Maintenance: The Role of the "Mixed Lineage Leukemia" Gene in Normal Blood Cell Development, Differentiation and Leukemia. |
 |
Paco Herson
Associate Professor
Ph.D., 1999, Univ. of Aberdeen, UK
Basic translational research using neurophysiology, biochemistry, molecular biology, histology and neuro-behavior to elucidate the mechanisms of neuronal injury and identify therapeutic targets for protection and repair.
|
 |
J. David Port
Professor
Ph.D., 1989, Univ. of Utah
G-protein linked receptors and their regulation; regulation of mRNA stability. |
 |
Richard J. Traystman
University Distinguished Professor and Vice Chancellor for Research
Ph.D., 1971, Johns Hopkins Univ.
Neuroscience, cerebrovascular physiology, stroke, cardiac arrest/CPR, respiration, cardiopulmonary physiology. |
 |
Dan TheodorescuProfessor and Director of the Univ. of Colorado Comprehensive Cancer CenterM.D., 1986, Queen's Univ. Faculty of Health Sciences; Ph.D., 1993, Univ. of Toronto
I'm a physician scientist. Our translational molecular biology laboratory focuses on identifying the molecular mechanisms leading to bladder cancer metastasis and their potential applications to patients with this disease. Our group is at the forefront of the development of biomarkers and therapeutics in bladder cancer. My clinical practice is limited to bladder cancer management including surgery such as radical cystectomy using state of the art robotic techniques (i.e. da Vinci). |
|
|